Pera Labs Malta vanishes after €800k grant

The Malta branch of a fertility technology company, Pera Labs, has seemingly disappeared from the island after benefiting from an €800,000 grant from the government agency Malta Enterprise. Once presented as a pioneering player in biomedical innovation, the company now stands accused of abandoning its operations, defaulting on rent payments, and leaving taxpayers with unanswered questions about how public money was spent.

A once-promising biotech venture

When Pera Labs first arrived in Malta, the company was heralded as a shining example of Malta Enterprise’s strategy to attract high-tech firms to the island. Established within the Mosta Technopark, Pera Labs Malta was promoted as a hub for cutting-edge biomedical research. The company claimed it was developing “AI-powered sperm analysis devices for fertility clinics,” a technology that was meant to revolutionize the fertility sector by improving the accuracy and efficiency of sperm selection during assisted reproduction.

Its CEO and sole shareholder, Burak Özkösem, a Turkish national, became the public face of the project. In 2022, he was featured prominently in local media, where he shared ambitious plans to position Malta at the forefront of fertility research through the use of artificial intelligence. At the time, Özkösem presented Pera Labs as an innovator that would create skilled jobs, attract international collaborations, and reinforce Malta’s reputation as a life sciences hub.

The disappearance from Mosta Technopark

Those grand claims appear to have evaporated. A site visit to Pera Labs’ registered location in the Mosta Technopark reveals that the premises are now deserted. The once-promising laboratory space is closed, and a legal notice affixed to its front door confirms that the property is under the control of INDIS Malta, the state agency that manages government-owned industrial estates.

The notice states that INDIS Malta is taking legal action to recover €62,021 in unpaid rent that has been outstanding since April 2023. The document also makes clear that Pera Labs’ failure to pay rent “constitutes a serious breach” of the lease agreement signed in November 2021.

According to INDIS Malta, further violations of the agreement include the company’s failure to keep the property in active use and not maintaining the agreed-upon number of employees required by the contract. These breaches raise questions about whether the company ever carried out the level of activity it had initially promised when securing the government’s support.

Legal warning and unpaid obligations

The legal letter displayed on the building details that the company not only failed to meet its rent obligations but also did not operate the facility according to the contractual terms. Such clauses typically require that tenants maintain a certain workforce size, use the premises for the stated industrial or research purpose, and comply with reporting obligations tied to government funding.

Given these violations, INDIS Malta has initiated proceedings to recover the funds owed. However, the process is complicated by the fact that the company appears to have ceased operations altogether, leaving little trace of its management, staff, or assets within Malta.

The mystery surrounding the €800,000 grant

Pera Labs Malta was awarded an €800,000 grant by Malta Enterprise, a sum meant to assist in developing and commercializing advanced fertility technologies. Yet, there is no evidence that the grant resulted in tangible outcomes.

The company’s official records, business filings, and public disclosures provide no indication of products brought to market, ongoing research, or intellectual property developed through this state-funded investment. Nor are there any recent statements from Malta Enterprise explaining how it monitored or evaluated Pera Labs’ performance following the grant.

This raises broader concerns about the oversight mechanisms in place for Malta Enterprise’s funding programs. Critics have long questioned whether the agency exercises sufficient due diligence before allocating large sums of taxpayer money to foreign or start-up entities with limited track records.

The CEO’s sudden disappearance and new role

Further confusion surrounds the company’s founder. According to Burak Özkösem’s LinkedIn profile, he is no longer involved with Pera Labs as of November 2024. Instead, he now identifies himself as an “independent consultant,” though without specifying the nature of his consultancy work or its location.

There is no mention of the Malta branch or of the company’s prior projects in his recent professional descriptions. His online presence gives the impression of a clean break from Pera Labs, leaving questions about whether he intends to return to Malta or continue similar ventures elsewhere.

Sparse records and financial opacity

A review of Malta’s business registry reveals that Pera Labs Malta remains technically active but has failed to submit audited accounts for the last four financial years. The company’s declared share capital amounts to only €1,200, the bare minimum required to maintain registration. This minimal capitalization stands in stark contrast to the company’s earlier claims of conducting international biomedical research.

The lack of publicly available financial data makes it impossible to determine how the €800,000 grant was utilized, whether any portion was spent in Malta, or if the company diverted funds elsewhere. No reports of local employees, laboratory results, or collaborations have surfaced since 2022.

Unrealized promises and missing technology

Back in 2022, Pera Labs promoted itself as being “at the centre of an international collaboration” involving its Philadelphia-based parent company. It was supposed to bridge American and European research teams in developing “AI-powered fertility solutions” designed to assist clinicians in selecting the best sperm samples for artificial insemination and in-vitro fertilization (IVF) procedures.

Despite these claims, there is no trace of such products being marketed, registered, or reviewed by regulatory authorities. A search for the company’s supposed devices or research outputs yields little information beyond its own promotional material. No medical publications, patents, or conference presentations appear to substantiate the company’s technological achievements.

Oversight concerns within Malta Enterprise

At the time Pera Labs received its funding, Malta Enterprise was led by Kurt Farrugia, a former communications aide to ex-Prime Minister Joseph Muscat. Farrugia’s leadership of the agency coincided with a series of controversies concerning the management of public funds and the selection of private beneficiaries.

Today, Farrugia serves as the CEO of Transport Malta, earning a salary reported at €12,500 per month—an increase from his previous remuneration at Malta Enterprise. The continuity of senior officials across multiple state entities has led some observers to argue that public accountability remains insufficient when it comes to overseeing taxpayer-funded projects.

Broader issues of public fund accountability

The Pera Labs case is not the first instance in which Malta Enterprise has been linked to projects that failed to deliver promised results. The agency has been previously scrutinized for its involvement in high-profile cases, including the hospitals concession inquiry, the Jean Paul Sofia public inquiry, and various commercial aviation projects that collapsed despite government support.

These incidents have raised ongoing concerns about the effectiveness of Malta’s investment policies, particularly regarding public-private partnerships and innovation funding. While the goal of attracting innovative enterprises to Malta is commendable, the recurring pattern of inadequate follow-up, poor performance verification, and limited transparency undermines public confidence.

Lack of response from involved parties

Requests for clarification have been sent to both Pera Labs and INDIS Malta. As of publication, neither entity has provided any formal response. The silence further fuels speculation about whether the company ever met its obligations under the grant conditions and whether the government intends to recover the funds.

The absence of a response also highlights a systemic problem in Malta’s public sector: limited communication with the media when public funds are involved in controversial or opaque situations. For now, the €800,000 grant appears to have vanished along with the company that received it.

Implications for Malta’s innovation reputation

The disappearance of Pera Labs Malta casts a shadow over Malta’s ambitions to position itself as a biotechnology hub within Europe. The country has made significant investments in attracting medical research and AI-driven innovation, yet such efforts are undermined when oversight mechanisms fail to ensure accountability.

For policymakers and regulators, this case serves as a reminder that the credibility of public investment programs depends not only on attracting companies but also on monitoring their performance and enforcing compliance. Without rigorous auditing and follow-up, Malta risks being perceived as a jurisdiction where state funding can be obtained with minimal scrutiny and limited consequences for non-performance.

Conclusion

The unfolding story of Pera Labs Malta serves as a sobering example of how ambitious innovation projects can falter when oversight and accountability fail to match the scale of public investment. What began as a celebrated partnership aimed at positioning Malta as a leader in biomedical technology has now devolved into a cautionary tale of missed promises, financial opacity, and unanswered questions.

The disappearance of the company, coupled with unpaid rent and a lack of transparency regarding the use of an €800,000 Malta Enterprise grant, underscores systemic weaknesses in how state agencies vet and monitor grant recipients. While innovation-driven investment is vital for national development, such programs must be governed by strict due diligence, ongoing audits, and clear mechanisms for recovery when companies fail to deliver.

Moreover, this case highlights a recurring issue in Malta’s public-private partnerships — the ease with which entities can secure substantial state support despite limited operational history, and the difficulty in holding them accountable afterward. The absence of timely communication from Pera Labs, INDIS Malta, and Malta Enterprise only deepens public concern about transparency in the management of taxpayer funds.

As Malta continues to promote itself as a destination for scientific and technological investment, it must also ensure that oversight institutions are equipped to prevent such lapses. Ensuring accountability, financial transparency, and legal compliance is not only necessary to protect public resources but also to preserve Malta’s international credibility as a trustworthy environment for innovation and enterprise.

Ultimately, the Pera Labs Malta case should serve as an opportunity for reflection and reform. Strengthening monitoring frameworks, enforcing contractual obligations, and demanding greater corporate accountability are essential steps toward rebuilding confidence in how public funds are allocated and managed. Only through greater transparency and responsibility can Malta truly realize its ambition of fostering a robust and credible innovation ecosystem.

FAQs

What was Pera Labs Malta supposed to do?
The company claimed it would develop AI-powered sperm analysis devices to assist fertility clinics in improving the accuracy of sperm selection for IVF treatments.

How much government funding did Pera Labs receive?
Pera Labs was awarded an €800,000 grant from Malta Enterprise to support its research and product development in biomedical technology.

Why is Pera Labs Malta in legal trouble?
The company allegedly failed to pay rent on its leased premises within the Mosta Technopark and breached several terms of its contract with INDIS Malta.

What does the legal notice on the property state?
The notice confirms that INDIS Malta is taking legal action to recover €62,021 in unpaid rent and cites serious breaches of contract by Pera Labs.

Is Pera Labs still operating in Malta?
As of now, the Malta facility appears abandoned, and no employees or active operations are visible at its registered address.

What happened to Pera Labs’ CEO, Burak Özkösem?
According to his LinkedIn profile, Özkösem is now working as an independent consultant and is no longer associated with Pera Labs.

Did Malta Enterprise monitor the company’s performance?
It is unclear whether Malta Enterprise conducted any follow-up or audit to ensure that the company fulfilled its obligations under the grant.

Are there any products or research results from Pera Labs?
No verifiable products, patents, or research outputs linked to Pera Labs Malta have been publicly documented since 2022.

What will happen to the unpaid rent and grant funds?
INDIS Malta is pursuing legal action for the rent arrears, but recovery of the government grant remains uncertain.

What lessons does this case highlight for Malta?
The incident underscores the importance of transparency, due diligence, and strict oversight when distributing public funds to private enterprises.